Home LiteratureArticle Details
PMID: 4398342 Published · ppublish English Clinical Trial Journal Article

Levodopa's awakening effect on patients with Parkinsonism.

Journal of neurology, neurosurgery, and psychiatry ·Vol. 34 ·No. 3 ·1971-06-00 ·Pages 209-18

Marsh GG, Markham CM, Ansel R

Abstract

The effects of levodopa on tests measuring auditory and visual perception, auditory, and visual short-term memory, verbal learning, and on attention and concentration were studied in 29 patients with Parkinsonism. Thirty-two control subjects matched with the Parkinsonism patients on age, educational level, and verbal IQ were administered the same tests to control for practice effects. Significant improvement occurred for the Parkinsonism patients in verbal learning (an intermediate memory test) and in auditory perception. These improvements were unrelated to changes in anticholinergic medications, increases in alertness or concentration, lessening of depression, or improved motor ability or control. There was no test evidence of levodopa improving visual perception, short-term auditory or visual memory, alertness or concentration. Thus, there is no objective test evidence for levodopa producing a generalized awakening or an alerting effect in Parkinsonism patients who are intellectually alert and well-orientated. Interpretation of the test findings suggests a specific awakening effect, that of improvement in intermediate memory but not in short-term memory. Overall, the Parkinsonism group scored below the control group on all tests, suggesting that cognitive impairment accompanies Parkinson's disease even in patients who are intellectually intact and well oriented.

MeSH Terms
Adult Aged Arousal/drug effects Attention/drug effects Auditory Perception Clinical Trials as Topic Cognition Dihydroxyphenylalanine/pharmacology,therapeutic use Humans MMPI Memory/drug effects Memory, Short-Term Middle Aged Orientation Parasympatholytics/therapeutic use Parkinson Disease/drug therapy,physiopathology Perception/drug effects Sound Thinking Verbal Learning/drug effects Visual Perception
Chemicals
Parasympatholytics Dihydroxyphenylalanine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Marsh G G
Markham C M
Ansel R
References (14)
14 references, click to expand
  1. Depressive symptoms in Parkinson patients referred for thalamotomy.
    J Neurol Neurosurg Psychiatry. 1967 Aug;30(4):368-70 PMID: 4228336
  2. Memory disturbance and the Parkinson syndrome.
    Br J Med Psychol. 1967 Jun;40(2):169-71 PMID: 6057369
  3. The measurement of memory in clinical practice.
    Br J Soc Clin Psychol. 1968 Feb;7(1):19-34 PMID: 5649563
  4. Modification of Parkinsonism--chronic treatment with L-dopa.
    N Engl J Med. 1969 Feb 13;280(7):337-45 PMID: 4178641
  5. Effects of L-dopa in Parkinson's disease.
    Lancet. 1969 Jul 26;2(7613):165-8 PMID: 4183130
  6. W.A.I.S. scores in a group of Parkinson patients.
    Br J Psychiatry. 1969 May;115(522):555-6 PMID: 5806844
  7. Treatment of parkinsonism with levodopa.
    Arch Neurol. 1969 Oct;21(4):343-54 PMID: 5820999
  8. Treatment of parkinsonism with L-dopa (study of 105 patients).
    Dis Nerv Syst. 1969 Nov;30(11):737-46 PMID: 5359046
  9. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    Ann Intern Med. 1970 Jan;72(1):29-35 PMID: 5410397
  10. Treatment of Parkinsonism with Laevo-dopa.
    Br Med J. 1970 Feb 7;1(5692):331-7 PMID: 4906702
  11. L-dopa in the treatment of post-surgical Parkinson patients.
    J Neurosurg. 1970 Mar;32(3):281-5 PMID: 5416910
  12. Psychiatric symptoms in Parkinsonism.
    J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):188-91 PMID: 5443478
  13. An abbreviation of the WAIS for clinical use.
    J Clin Psychol. 1962 Jan;18:77-9 PMID: 14497487
  14. Cognitive function in Parkinson's disease.
    J Nerv Ment Dis. 1962 Sep;135:196-205 PMID: 13984777
Article Info
Journal
Journal of neurology, neurosurgery, and psychiatry
Abbr.
J Neurol Neurosurg Psychiatry
ISSN
0022-3050
Published
1971-06-00
Pages
209-18
Language
English
Region
England
NLM ID
2985191R
PMCID
PMC1083453
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com